Companion Diagnostics

Companion Diagnostics is a regulatory and clinical biomarker-based diagnostic strategy that identifies patients most likely to benefit from a specific therapeutic product, thereby enabling targeted therapeutic decision-making in precision medicine.

72

Publications

2.1K

Citations

301

Authors

128

Institutions

Publications per year

2017–2026

23

Authors

301

  1. JT
    Jan Trøst Jørgensen

    DXC Technology (United States), United States

    6 publications · 187 citations

    6

    h-index

  2. RP
    Reena Philip

    United States Food and Drug Administration, United States

    3 publications · 247 citations

    3

    h-index

  3. ML
    Meijuan Li

    Tianjin Anding Hospital, China

    3 publications · 66 citations

    3

    h-index

  4. RP
    Richard Pazdur

    United States Food and Drug Administration, United States

    3 publications · 312 citations

    3

    h-index

  5. DL
    David L. Rimm

    Yale University, United States

    3 publications · 59 citations

    3

    h-index

1–5 of 301

Venues

  1. Clinical Cancer Research

    10 publications · 615 citations

    10

    h-index

  2. Expert Review of Molecular Diagnostics

    4 publications · 94 citations

    4

    h-index

  3. Biomarkers in Medicine

    3 publications · 67 citations

    3

    h-index

  4. JNCI Journal of the National Cancer Institute

    2 publications · 27 citations

    2

    h-index

  5. Personalized Medicine

    2 publications · 24 citations

    2

    h-index

1–5